Direct-to-Brain chemo tested against standard treatment for aggressive breast cancer spread
NCT ID NCT06230055
Summary
This study compares two treatment approaches for HER2-negative breast cancer that has spread to the membranes surrounding the brain and spinal cord. Researchers are testing whether delivering chemotherapy directly into spinal fluid through a small reservoir device, combined with standard chemotherapy, works better than standard chemotherapy alone. The trial will measure how long patients live without their neurological symptoms worsening, and will track their quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HER2-NEGATIVE BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.